Effect of collision material on COR. by Yifei Li (198040)

Subjects:

Effect of collision speed on COR. by Yifei Li (198040)

Subjects:

Computational parameters used in the simulations. by Yifei Li (198040)

Subjects:

Comparison between simulation tests and bench tests. by Yifei Li (198040)

Subjects:

Schematic diagram of analog three-dimensional coordinate system testing device. by Yifei Li (198040)

Subjects:

Collision materials. by Yifei Li (198040)

Subjects:

Box plots of the three-dimensional displacement variations and the COR. by Yifei Li (198040)

Subjects:

Comparison between simulation tests and bench tests. by Yifei Li (198040)

Subjects:

Diagram of displacement variation. by Yifei Li (198040)

Subjects:

Scheme and results of orthogonal test. by Yifei Li (198040)

Subjects:

Comparison between simulation tests and bench tests. by Yifei Li (198040)

Subjects:

The millet mode. by Yifei Li (198040)

Subjects:

Voxel-based whole-brain analysis shows regional and dose-dependent effects of netoglitazone in decreasing plaque count. by Francesca Catto (21253435)

“…Each map represents a 3-dimensional view of statistically affected voxels (p < 0.05), where the red scale indicates a decrease in plaque count, and the cyan scale represents an increase. …”

Technical properties of tested UASs. by Marc Roswag (20598443)

“…Our results support this hypothesis, because multicopter flights have a highly significant negative impact on bat activity levels with a medium effect size, particularly for the Myotini (<i>P</i> < 0.001, <i>d</i>_<i>m</i> = 0.54) and Nyctaloid group (<i>P</i> < 0.001, <i>d</i>_<i>n</i> = 0.55) and a small effect size for the Pipistrelloid group (<i>P</i> < 0.001, <i>d</i>_<i>p</i> = 0.36). …”

Summary of Biomarker Expression in Benign Samples. The STT and LTT groups exhibit significant changes in biomarker expression compared to the nontreatment group, measured on a two-... by Jinho Lee (587173)

Subjects:

(A) Cardiovascular Disease and (B) type-2 Diabetes Mellitus, and (C) chronic kidney disease- related Age-Adjusted Mortality Rates per 100,000 in Adults in the United States, 1999 t... by Aman Goyal (19231397)

Subjects:

Annual incidence of insomnia disorder (ICD-CODE: G47) Bar: rate of insomnia disorder relative to all patients; Line: average number of outpatient visits for patients with insomnia... by Mingee Choi (15250732)

Subjects: “…treatment initiation decreased…”

Distribution of non-pharmacological treatment related to insomnia disorder (2002–2019). by Mingee Choi (15250732)

Subjects: “…treatment initiation decreased…”

Detailed treatment status of patients who did not receive non-pharmacological treatment at first diagnosis but received it later. by Mingee Choi (15250732)

Subjects: “…treatment initiation decreased…”

Mean interval from initial diagnosis to initiation of non-pharmacological treatment by year. by Mingee Choi (15250732)

Subjects: “…treatment initiation decreased…”